P/E ratio for Pediatrix Medical Group (MD)
P/E ratio as of April 2024 (TTM): 8.19
According to Pediatrix Medical Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 8.19461. At the end of 2022 the company had a P/E ratio of 18.6.
P/E ratio history for Pediatrix Medical Group from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 18.6 | 4.75% |
| 2021 | 17.8 | -790.09% |
| 2020 | -2.58 | 67.31% |
| 2019 | -1.54 | -113.7% |
| 2018 | 11.2 | -27.59% |
| 2017 | 15.5 | -18.41% |
| 2016 | 19.0 | -4.17% |
| 2015 | 19.9 | -3.31% |
| 2014 | 20.5 | 7.5% |
| 2013 | 19.1 | 18.22% |
| 2012 | 16.2 | 1.61% |
| 2011 | 15.9 | 2.8% |
| 2010 | 15.5 | -1.37% |
| 2009 | 15.7 | 81.08% |
| 2008 | 8.66 | -62.51% |
| 2007 | 23.1 | 11.02% |
| 2006 | 20.8 | -46.43% |
| 2005 | 38.8 | 145.76% |
| 2004 | 15.8 | 2.14% |
| 2003 | 15.5 | 3.14% |
| 2002 | 15.0 | -38.07% |
| 2001 | 24.2 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Universal Health Services
UHS | 17.2 | 110.45% | 🇺🇸 USA |
 Community Health Systems
CYH | 1.66 | -79.79% | 🇺🇸 USA |
 Tenet Healthcare THC | 21.5 | 161.81% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.